First Drug for BRCA Breast Cancer: Olaparib First Drug for BRCA Breast Cancer: Olaparib

Olaparib has achieved two firsts in breast cancer: it ' s the first PARP inhibitor and the first drug for patients carrying the BRCA mutation.FDA Approvals
Source: Medscape Today Headlines - Category: Consumer Health News Tags: Hematology-Oncology News Alert Source Type: news